Patient-Reported Outcomes With Belantamab Mafodotin Treatment in Patients With Triple-Class Refractory Multiple Myeloma.

Details

Language :

English

ISSN :

21500878

Volume :

14

Issue :

6

Database :

Supplemental Index

Journal :

JADPRO: Journal of the Advanced Practitioner in Oncology

Publication Type :

Academic Journal

Accession number :

172039468

Full Text :

https://doi.org/10.6004/jadpro.2023.14.6.4